Vancomycin Injection, Solution
NDC Package 70594-044-02
Package Information
Vancomycin injection is vancomycin is used to treat serious bacterial infections. This formulation utilizes a injection, solution delivery system. Marketed by Xellia Pharmaceuticals Usa Llc, this product is identified by NDC 70594-044 and is authorized under FDA application NDA211962.
Identification & Billing
- RxCUI: 1807508 - vancomycin 1 GM in 200 ML Injection
- RxCUI: 1807508 - 200 ML vancomycin 5 MG/ML Injection
- RxCUI: 1807508 - vancomycin (as vancomycin hydrochloride) 1 GM per 200 ML Injection
- RxCUI: 1807508 - vancomycin 1 GM per 200 ML Injection
- RxCUI: 1807510 - vancomycin 750 MG in 150 ML Injection
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 70594 - Xellia Pharmaceuticals Usa Llc
- 70594-044 - Vancomycin
- 70594-044-02 - 6 BAG in 1 CARTON / 400 mL in 1 BAG (70594-044-01)
- 70594-044 - Vancomycin
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 70594-044-02 identifies a specific commercial package of 6 bag in 1 carton / 400 ml in 1 bag (70594-044-01) of Vancomycin, a human prescription drug labeled by Xellia Pharmaceuticals Usa Llc. This injection, solution is formulated for intravenous use and contains vancomycin as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Xellia Pharmaceuticals Usa Llc on February 15, 2019. The current certification is valid through December 31, 2026.
What are the primary indications for this medication?
Vancomycin is used to treat serious bacterial infections. It is an antibiotic that works by stopping the growth of bacteria. This medication is usually given by injection into a vein. However, the form in vials may also be given by mouth to treat a certain intestinal condition (colitis) that may rarely happen after treatment with antibiotics. This condition causes diarrhea and stomach/abdominal discomfort or pain. When vancomycin is taken by mouth, it stays in the intestines to stop the growth of bacteria that cause these symptoms. This antibiotic treats only bacterial infections. It will not work for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections.
How is this Xellia Pharmaceuticals Usa Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 70594004402. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.